Get Free Delivery With No Minimum Order

AMYDRAMINE EXPECTORANT SYRUP SUGAR FREE 120ML
- Sku : I-030880
Key features
AMYDRAMINE Expectorant Syrup Sugar Free 120 mL is a sugar‑free syrup containing sodium citrate 5.7 mg/mL and diphenhydramine hydrochloride 1.4 mg/mL. Diphenhydramine is a first‑generation H1 antihistamine with central antitussive and anticholinergic effects to reduce histamine‑mediated symptoms and suppress cough, while sodium citrate alkalinizes secretions to reduce mucus viscosity and promote expectoration. It is indicated for symptomatic relief of cough associated with upper respiratory tract infections and the common cold when an antihistamine/antitussive is appropriate, and for relief of allergic symptoms such as rhinitis. Available OTC in a 120 mL syrup.- Brand: AMYDRAMINE
- Active Ingredient: SODIUM CITRATE 5.7mg/ml, DIPHENHYDRAMINE HYDROCHLORIDE 1.4mg/ml
- Strength: 5.7,1.4mg/ml
- Dosage Form: Syrup
- Pack Size: 120 ml
- Route: Oral use
- Prescription Status: OTC
- Therapeutic Class: Antiallergic
- Pharmacological Group: Antihistamines
- Drug Class: First-generation H1 antihistamine (diphenhydramine) with antitussive/sedative and anticholinergic properties + alkalinizing/expectorant agent (sodium citrate).
- Manufacturer: Gulf Pharmaceutical Industries (Julphar)
- Country of Origin: United Arab Emirates
- SFDA Registration No.: 0307257683
- Shelf Life: 24 months
- Storage: store below 25°c
- Symptom Target: Cough, Allergy, Runny Nose
- Sedating: Yes
Indications
Approved Uses
Symptomatic relief of cough associated with upper respiratory tract infections/common cold where an antihistamine/antitussive is appropriate, and relief of allergic symptoms (e.g., rhinitis) where diphenhydramine is indicated.
Off-Label Uses
Diphenhydramine (the active ingredient) is used off-label for short-term insomnia and for prevention/treatment of motion sickness; acute dystonic reactions are treated with diphenhydramine in clinical settings (typically injectable), not with this expectorant syrup product.
Dosage & Administration
Dosing by Condition
Use per local product label; typical diphenhydramine-containing cough/allergy syrup dosing is: Adults and ≥12 years: 10 mL every 4-6 hours as needed (max 6 doses/24 h). Children 6-11 years: 5 mL every 4-6 hours as needed (max 6 doses/24 h). Children 2-5 years: 2.5 mL every 4-6 hours as needed (max 6 doses/24 h). Do not use in children <2 years unless specifically directed by a clinician.
How to Take
Shake well before use. Measure doses with a calibrated measuring spoon/cup or oral syringe. May be taken with or without food; if stomach upset occurs, take with food. Use the lowest effective dose for the shortest duration and do not exceed the labeled maximum daily dose.
Side Effects
Common Side Effects
Drowsiness/sedation, dizziness, dry mouth/nose/throat, blurred vision, constipation, nausea/epigastric upset, urinary retention, and impaired coordination (especially with alcohol/CNS depressants).
Side Effect Frequency
Common/very common: drowsiness/sedation and anticholinergic effects (dry mouth, dizziness); Other common: impaired coordination, blurred vision, constipation, nausea/epigastric discomfort; Less common/uncommon: paradoxical excitation (especially in children), palpitations, hypotension, urinary retention/hesitancy.
Safety & Warnings
Contraindications
Hypersensitivity to diphenhydramine (or any component); neonates and premature infants; breastfeeding; concomitant use of MAO inhibitors (or within 14 days); narrow-angle glaucoma; urinary retention/prostatic hypertrophy; pyloroduodenal obstruction/stenosing peptic ulcer.
Warnings & Precautions
May cause significant drowsiness-avoid driving/alcohol/CNS depressants; use caution in asthma/COPD, glaucoma, urinary retention/BPH, cardiovascular disease, hyperthyroidism, seizure disorders; paradoxical excitation may occur in children; avoid use in children <2 years; older adults are at higher risk of confusion/falls due to anticholinergic effects; do not exceed recommended dosing.
Age Restriction
Not recommended in children under 2 years (and contraindicated in neonates/premature infants).
Drug Interactions
Drug Interactions
MAO inhibitors; alcohol; other CNS depressants (e.g., benzodiazepines, opioids, sedative-hypnotics); other antihistamines; anticholinergic drugs (including TCAs and some antipsychotics).
Interaction Severity
MAJOR: Alcohol and other CNS depressants (e.g., opioids, benzodiazepines) due to additive sedation/respiratory depression; concomitant sedating antihistamines. MODERATE: Other anticholinergics (e.g., TCAs, antipsychotics) increasing anticholinergic burden; MAOIs may enhance/prolong anticholinergic/CNS effects-avoid or use only with medical advice.
Food Interaction
No restriction
Storage & Patient Advice
Missed Dose
If used on a schedule, take the missed dose when remembered unless it is close to the next dose; then skip and resume the regular schedule. Do not double doses.
Stopping the Medicine
May be stopped at any time when no longer needed; no taper is required.
Overdose
Symptoms: marked drowsiness or agitation (esp. children), confusion, hallucinations/delirium, anticholinergic signs (dry mouth, mydriasis, tachycardia, urinary retention, flushing), seizures, arrhythmias/QT prolongation, respiratory depression, coma; Management: urgent medical care/poison center, activated charcoal if appropriate, supportive care (airway/ventilation, benzodiazepines for seizures), ECG monitoring; physostigmine may be considered for severe anticholinergic delirium in selected cases under expert supervision.
Patient Counseling
May cause marked drowsiness and impaired coordination-avoid driving/operating machinery. Avoid alcohol and other sedatives; do not combine with other products containing diphenhydramine/antihistamines. Measure doses accurately and shake well. Do not use in children <2 years unless directed by a clinician. Seek medical advice if symptoms persist >7 days, worsen, or are accompanied by fever, rash, or breathing difficulty. Sugar-free; store below 25°C and keep out of reach of children.
Monitoring Requirements
No routine monitoring required for short-term OTC use
Pharmacology
Mechanism of Action
Diphenhydramine is a first-generation H1 antihistamine (inverse agonist) that reduces histamine-mediated symptoms and can suppress cough via central effects; it also has anticholinergic and sedative activity. Sodium citrate acts as an alkalinizing agent that can reduce mucus viscosity and facilitate expectoration.
Onset of Action
15-60 minutes.
Duration of Effect
4-7 hours.
Metabolism
Diphenhydramine: extensive hepatic metabolism (primarily CYP2D6; also other CYPs such as CYP1A2/CYP2C9/CYP2C19/CYP3A4 reported) via N-demethylation and oxidative pathways; Sodium citrate: metabolized in the liver and peripheral tissues to bicarbonate as part of normal citrate metabolism.
Excretion
Diphenhydramine: primarily renal excretion as metabolites (with only a small fraction as unchanged drug); Sodium citrate: metabolized to bicarbonate/CO2 and ultimately excreted mainly via the kidneys as bicarbonate/alkali load (with CO2 eliminated via lungs).
Product Information
Available Dosage Forms
Syrup (oral).
Generic Availability
Yes
Symptom Target
Cough, Allergy, Runny Nose
Sedating
Yes
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)


